1-6 of 6
Authors: N Lynn Henry
Sort by
Journal Article
ACCEPTED MANUSCRIPT
Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial
Hanna Bandos and others
JNCI Cancer Spectrum, pkaf032, https://doi.org/10.1093/jncics/pkaf032
Published: 01 April 2025
Journal Article
Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms
N Lynn Henry and others
JNCI Cancer Spectrum, Volume 5, Issue 6, December 2021, pkab087, https://doi.org/10.1093/jncics/pkab087
Published: 30 October 2021
Journal Article
Disparities in Cardiovascular Disease Risk Among Hispanic Breast Cancer Survivors in a Population-Based Cohort
Qingqing Hu and others
JNCI Cancer Spectrum, Volume 5, Issue 2, April 2021, pkab016, https://doi.org/10.1093/jncics/pkab016
Published: 15 February 2021
Journal Article
Adverse Events and Perception of Benefit From Duloxetine for Treating Aromatase Inhibitor-Associated Arthralgias
Patrick M Schnell and others
JNCI Cancer Spectrum, Volume 5, Issue 2, April 2021, pkab018, https://doi.org/10.1093/jncics/pkab018
Published: 08 February 2021
Journal Article
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions
Ryan J O Dowling and others
JNCI Cancer Spectrum, Volume 3, Issue 4, December 2019, pkz049, https://doi.org/10.1093/jncics/pkz049
Published: 10 August 2019
Journal Article
Toronto Workshop on Late Recurrence in Estrogen Receptor–Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations
Ryan J O Dowling and others
JNCI Cancer Spectrum, Volume 3, Issue 4, December 2019, pkz050, https://doi.org/10.1093/jncics/pkz050
Published: 10 August 2019
Advertisement
Advertisement